Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-03
2011-12-27
Saeed, Kamal (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S414000
Reexamination Certificate
active
08084621
ABSTRACT:
3-pyrrolo[b]cyclohexylene-2-dihydro-indolinone derivatives of formula (I) or their pharmaceutically acceptable salts and uses thereof. The intermediates of formula (II) for preparing the above compounds. The bioassay shows that the above compounds and their pharmaceutically acceptable salts can modulate the activity of protein kinases (PKs), inhibit the activity of tyrosine kinases (PTKs) and inhibit many kinds of tumor cells as well as.
REFERENCES:
patent: 6642251 (2003-11-01), Tang et al.
patent: WO 00/12084 (2000-03-01), None
patent: WO 01/37819 (2001-05-01), None
patent: WO 01/60814 (2001-08-01), None
patent: WO 02/092079 (2002-11-01), None
patent: WO 03/035009 (2003-05-01), None
patent: WO 2005/053686 (2005-06-01), None
Ding Lei
Jin Qiu
Lu Shiyue
Shen Han
Tang Feng
Global IP Services
Grazier Nyeemah A
Gu Tianhua
Jiangsu Simcere Pharmaceutical R&D Co. Ltd.
Saeed Kamal
LandOfFree
3-Pyrrolo[ b ]cyclohexylene-2-dihydroindolinone derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Pyrrolo[ b ]cyclohexylene-2-dihydroindolinone derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Pyrrolo[ b ]cyclohexylene-2-dihydroindolinone derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266718